iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Ferris Capital LLC

Ferris Capital LLC grew its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 1,626.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,890 shares of the financial services provider’s stock after purchasing an additional 24,390 shares during the quarter. iShares NASDAQ Biotechnology Index comprises about 1.0% of Ferris Capital LLC’s investment portfolio, making the stock its 20th biggest position. Ferris Capital LLC’s holdings in iShares NASDAQ Biotechnology Index were worth $2,764,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. FNY Partners Fund LP bought a new position in shares of iShares NASDAQ Biotechnology Index during the 3rd quarter valued at $133,000. Wharton Business Group LLC bought a new position in shares of iShares NASDAQ Biotechnology Index during the 3rd quarter valued at $208,000. New England Investment & Retirement Group Inc. bought a new position in shares of iShares NASDAQ Biotechnology Index during the 3rd quarter valued at $213,000. Leavell Investment Management Inc. bought a new position in shares of iShares NASDAQ Biotechnology Index during the 3rd quarter valued at $214,000. Finally, Fishman Jay A Ltd. MI bought a new position in shares of iShares NASDAQ Biotechnology Index during the 3rd quarter valued at $247,000. Institutional investors and hedge funds own 27.28% of the company’s stock.

iShares NASDAQ Biotechnology Index (IBB) opened at $110.36 on Friday. iShares NASDAQ Biotechnology Index has a twelve month low of $94.20 and a twelve month high of $119.30.

TRADEMARK VIOLATION WARNING: “iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Ferris Capital LLC” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://stocknewstimes.com/2018/02/18/ishares-nasdaq-biotechnology-index-ibb-shares-bought-by-ferris-capital-llc.html.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Ferris Capital LLC

Ferris Capital LLC boosted its position in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 1,626.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,890 shares of the financial services provider’s stock after buying an additional 24,390 shares during the quarter. iShares NASDAQ Biotechnology Index makes up about 1.0% of Ferris Capital LLC’s holdings, making the stock its 20th biggest position. Ferris Capital LLC’s holdings in iShares NASDAQ Biotechnology Index were worth $2,764,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. CHURCHILL MANAGEMENT Corp grew its stake in iShares NASDAQ Biotechnology Index by 223.2% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 1,801,330 shares of the financial services provider’s stock valued at $192,328,000 after buying an additional 1,244,066 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in iShares NASDAQ Biotechnology Index by 175.5% in the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 635,875 shares of the financial services provider’s stock valued at $212,132,000 after buying an additional 405,091 shares during the last quarter. Main Management LLC grew its position in iShares NASDAQ Biotechnology Index by 190.5% in the 4th quarter. Main Management LLC now owns 461,801 shares of the financial services provider’s stock worth $49,306,000 after purchasing an additional 302,839 shares during the last quarter. Lockheed Martin Investment Management Co. grew its position in iShares NASDAQ Biotechnology Index by 200.0% in the 4th quarter. Lockheed Martin Investment Management Co. now owns 329,400 shares of the financial services provider’s stock worth $35,170,000 after purchasing an additional 219,600 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. grew its position in iShares NASDAQ Biotechnology Index by 199.9% in the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 313,485 shares of the financial services provider’s stock worth $33,470,000 after purchasing an additional 208,963 shares during the last quarter. Institutional investors and hedge funds own 27.28% of the company’s stock.

Shares of iShares NASDAQ Biotechnology Index (NASDAQ IBB) opened at $110.36 on Friday. iShares NASDAQ Biotechnology Index has a 12-month low of $94.20 and a 12-month high of $119.30.

ILLEGAL ACTIVITY WARNING: “iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Ferris Capital LLC” was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://stocknewstimes.com/2018/02/18/ishares-nasdaq-biotechnology-index-ibb-shares-bought-by-ferris-capital-llc.html.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply